Similarly, for TNF‐α (Figure 2B), the pooled SMD was 1.80 (95% CI: 1.03‐2.56; P = .000), indicating that an elevated level of TNF‐α in the peripheral blood is significantly associated with an increased glioma risk. Here, TNF is linked to central nervous system cancer.